Shandra S. Wilson, MD
Practice Plan Director of Urologic Oncology
Clinical Interests Dr. Wilson’s primary areas of interest include urothelial cancer, testicular cancer and surgical and brachytherapeutic treatment of prostate cancer. Dr. Wilson is also specialty-trained in the creation of continent urinary diversion following bladder removal. Dr. Wilson also sees patients with benign prostatic hypertrophy, erectile dysfunction, urinary incontinence, elevated PSA, hematuria, and patients desiring vasectomy or circumcision.
Medical School Washington University School of Medicine
Residency University of Southern California and University of Mississippi
Fellowships University of Colorado School of Medicine (urologic oncology)
Board Certification Urology
Shandra S. Wilson, MD has been recruited as an Assistant Professor in the Division of Urology at the University of Colorado School of Medicine, beginning October 1st, 2004. Dr. Wilson was raised in Colorado and received her Bachelor of Science in Biology and Bachelor of Arts in Sociology degrees from the University of Denver. She received her Doctorate of Medicine from Washington University in St. Louis, Missouri under the guidance of Dr. Bill Catalona and completed her residency in urology at the University of Southern California under the tutelage of Dr. Donald Skinner. Dr. Wilson completed a fellowship in urologic oncology at Colorado University under the directorship of Dr. E. David Crawford.
Dr. Wilson’s primary clinical interest is urologic oncology with an emphasis on bladder, testicular, and prostatic carcinoma. She also specializes in reconstruction or substitution of the ureter and bladder and is adept at performing retroperitoneal lymph node dissections for testicular carcinoma. Dr. Wilson has learned the technique of nerve sparing prostatectomy from Dr. Gary Lievskovsky, a student of Dr. Patrick Walsh, and provides an opportunity for many of her patients to obtain cure without sacrificing continence or potency.
Dr. Wilson’s research interests are an extension of her clinical practice with an emphasis in the clinical aspects and molecular biology of testicular and bladder cancer. She is a member of the Southwestern Oncology Group and hopes to be a primary investigator in a multi-national trial. Dr. Wilson has authored numerous clinical papers, textbook chapters and has presented nationally on various aspects of urologic oncology. She has recently published a chapter in Urologic Clinics of North America on the complex issue of prostate cancer screening in the 21st century.
The Division of Urology at the University of Colorado is committed to improving the survival and overall quality of life for patients with genitourinary cancer and we are pleased to have Dr. Wilson on the full-time faculty at our institution. We are committed to excellence in surgery, patient care, and further research in the ever-evolving area of urologic oncology and feel Dr. Wilson provides and important resource to both patients and medical providers in the Rocky Mountain region.